iences company committed to revolutionizing the use of living cells in life science research and cellular therapy. The Company combines expertise in high-speed cell imaging and laser-based manipulation to develop products that enable novel cell imaging, purification, and transfection capabilities to enhance the productivity of laboratory research, recombinant protein production, high-content cellular assays, functional genomics and proteomics, and cell purification, including processing of cells for therapeutic transplantation. For additional information please visit the Company's web site at
www.cyntellect.com.
'/>"/>SOURCE Cyntellect, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
University of Florida and Cyntellect Collaborate to Unlock Mysteries of Cancer Stem Cells2.
Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development3.
Cyntellect to Collaborate With the Burnham Institute for Medical Research4.
InCode BioPharmaceutics Appoints New President and CEO5.
Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee6.
GeneNews appoints Canadian Colorectal Cancer Advisory Board7.
WuXi PharmaTech Appoints Ying Han to Its Board of Directors8.
TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors9.
Accumetrics Appoints John J. Young, MD Chief Medical Officer10.
Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board11.
Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer